LionBird — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Mana Biomana.bioinOct 2023
Mana.bio is a biotech company that uses machine learning and high-throughput screening to design lipid nanoparticles for targeted delivery of nucleic acid therapeutics and vaccines.
AI & Machine LearningBiotechSan Francisco, US
Yogev Debbi(Founder)inRoy Nevo(Founder)
Co-investorsAndreessen HorowitzNFX
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.